Difference between revisions of "Template:Histaminergics"
From Self-sufficiency
m (1 revision) |
m (1 revision: World Health Organization essential medicines) |
||
| (3 intermediate revisions by 2 users not shown) | |||
| Line 5: | Line 5: | ||
| state = collapsed | | state = collapsed | ||
| − | | group1 = [[ | + | | group1 = [[Histamine receptor|Receptor]]<br>[[ligand]]s |
| list1 = {{Navbox subgroup | | list1 = {{Navbox subgroup | ||
| groupstyle = background-color: LightYellow | | groupstyle = background-color: LightYellow | ||
| group1 = [[Histamine H1 receptor|H<sub>1</sub>]] | | group1 = [[Histamine H1 receptor|H<sub>1</sub>]] | ||
| − | | list1 = '''Agonists''': [[2-Pyridylethylamine]]{{•}} [[Betahistine]]{{•}} [[Histamine]]{{•}} [[Histamine trifluoromethyl toluidide|HTMT]]{{•}} [[UR-AK49]]<br/>'''Antagonists''': ''1st | + | | list1 = '''Agonists''': [[2-Pyridylethylamine]]{{•}} [[Betahistine]]{{•}} [[Histamine]]{{•}} [[Histamine trifluoromethyl toluidide|HTMT]]{{•}} [[UR-AK49]]<br/>'''Antagonists''': '''''1st generation''''': [[4-Methyldiphenhydramine]]{{•}} [[Alimemazine]]{{•}} [[Antazoline]]{{•}} [[Azatadine]]{{•}} [[Bamipine]]{{•}} [[Benzatropine]] (Benztropine){{•}} [[Bepotastine]]{{•}} [[Bromazine]]{{•}} [[Brompheniramine]]{{•}} [[Buclizine]]{{•}} [[Captodiame]]{{•}} [[Carbinoxamine]]{{•}} [[Chlorcyclizine]]{{•}} [[Chloropyramine]]{{•}} [[Chlorothen]]{{•}} [[Chlorpheniramine]]{{•}} [[Chlorphenoxamine]]{{•}} [[Cinnarizine]]{{•}} [[Clemastine]]{{•}} [[Clobenzepam]]{{•}} [[Clocinizine]]{{•}} [[Cyclizine]]{{•}} [[Cyproheptadine]]{{•}} [[Dacemazine]]{{•}} [[Deptropine]]{{•}} [[Dexbrompheniramine]]{{•}} [[Dexchlorpheniramine]]{{•}} [[Dimenhydrinate]]{{•}} [[Dimetindene]]{{•}} [[Diphenhydramine]]{{•}} [[Diphenylpyraline]]{{•}} [[Doxylamine]]{{•}} [[Embramine]]{{•}} [[Etybenzatropine]] (Ethylbenztropine){{•}} [[Etymemazine]]{{•}} [[Histapyrrodine]]{{•}} [[Homochlorcyclizine]]{{•}} [[Hydroxyethylpromethazine]]{{•}} [[Hydroxyzine]]{{•}} [[Isopromethazine]]{{•}} [[Isothipendyl]]{{•}} [[Meclozine]]{{•}} [[Mepyramine]] (Pyrilamine){{•}} [[Mequitazine]]{{•}} [[Methafurylene]]{{•}} [[Methapyrilene]]{{•}} [[Methdilazine]]{{•}} [[Moxastine]]{{•}} [[Niaprazine]]{{•}} [[Orphenadrine]]{{•}} [[Oxatomide]]{{•}} [[Oxomemazine]]{{•}} [[Phenindamine]]{{•}} [[Pheniramine]]{{•}} [[Phenyltoloxamine]]{{•}} [[Pimethixene]]{{•}} [[Piperoxan]]{{•}} [[Promethazine]]{{•}} [[Propiomazine]]{{•}} [[Pyrrobutamine]]{{•}} [[Talastine]]{{•}} [[Thenalidine]]{{•}} [[Thenyldiamine]]{{•}} [[Thiazinamium]]{{•}} [[Thonzylamine]]{{•}} [[Tolpropamine]]{{•}} [[Tripelennamine]]{{•}} [[Triprolidine]]; '''''2nd generation''''': [[Acrivastine]]{{•}} [[Astemizole]]{{•}} [[Azelastine]]{{•}} [[Cetirizine]]{{•}} [[Clemizole]]{{•}} [[Clobenztropine]]{{•}} [[Ebastine]]{{•}} [[Emedastine]]{{•}} [[Epinastine]]{{•}} [[Ketotifen]]{{•}} [[Latrepirdine]]{{•}} [[Levocabastine]]{{•}} [[Loratadine]]{{•}} [[Mebhydrolin]]{{•}} [[Mizolastine]]{{•}} [[Olopatadine]]{{•}} [[Rupatadine]]{{•}} [[Setastine]]{{•}} [[Terfenadine]]; '''''3rd generation''''': [[Desloratadine]]{{•}} [[Fexofenadine]]{{•}} [[Levocetirizine]]; '''''Miscellaneous''''': [[Tricyclic antidepressant|Tricyclic Antidepressant]]s ([[Amitriptyline]], [[Doxepin]], [[Trimipramine]], etc){{•}} [[Tetracyclic antidepressant|Tetracyclic Antidepressant]]s ([[Mianserin]], [[Mirtazapine]], etc){{•}} [[Serotonin antagonist and reuptake inhibitor|Serotonin Antagonists and Reuptake Inhibitor]]s ([[Trazodone]], [[Nefazodone]]){{•}} [[Typical antipsychotic|Typical Antipsychotic]]s ([[Chlorpromazine]], [[Thioridazine]], etc){{•}} [[Atypical antipsychotic|Atypical Antipsychotic]]s ([[Clozapine]], [[Olanzapine]], [[Quetiapine]], etc) |
| group2 = [[Histamine H2 receptor|H<sub>2</sub>]] | | group2 = [[Histamine H2 receptor|H<sub>2</sub>]] | ||
| − | | list2 = '''Agonists''': [[Amthamine]]{{•}} [[Betazole]]{{•}} [[Dimaprit]]{{•}} [[Histamine]]{{•}} [[Histamine trifluoromethyl toluidide|HTMT]]{{•}} [[Impromidine]]{{•}} [[UR-AK49]]<br/>'''Antagonists''': [[Cimetidine]]{{•}} [[Famotidine]]{{•}} [[Lafutidine]]{{•}} [[Lavoltidine]]{{•}} | + | | list2 = '''Agonists''': [[Amthamine]]{{•}} [[Betazole]]{{•}} [[Dimaprit]]{{•}} [[Histamine]]{{•}} [[Histamine trifluoromethyl toluidide|HTMT]]{{•}} [[Impromidine]]{{•}} [[UR-AK49]]<br/>'''Antagonists''': [[Bisfentidine]]{{•}} [[Burimamide]]{{•}} [[Cimetidine]]{{•}} [[Dalcotidine]]{{•}} [[Donetidine]]{{•}} [[Ebrotidine]]{{•}} [[Etintidine]]{{•}} [[Famotidine]]{{•}} [[Lafutidine]]{{•}} [[Lamtidine]]{{•}} [[Lavoltidine]]/[[Loxtidine]]{{•}} [[Lupitidine]]{{•}} [[Metiamide]]{{•}} [[Mifentidine]]{{•}} [[Niperotidine]]{{•}} [[Nizatidine]]{{•}} [[Osutidine]]{{•}} [[Oxmetidine]]{{•}} [[Pibutidine]]{{•}} [[Quisultidine]]/[[Quisultazine]]{{•}} [[Ramixotidine]]{{•}} [[Ranitidine]]{{•}} [[Roxatidine]]{{•}} [[Sufotidine]]{{•}} [[Tiotidine]]{{•}} [[Tuvatidine]]{{•}} [[Venritidine]]{{•}} [[Zaltidine]] |
| group3 = [[Histamine H3 receptor|H<sub>3</sub>]] | | group3 = [[Histamine H3 receptor|H<sub>3</sub>]] | ||
| Line 23: | Line 23: | ||
}} | }} | ||
| − | | group2 = [[ | + | | group2 = [[Reuptake inhibitor|Reuptake<br>inhibitor]]s |
| list2 = {{Navbox subgroup | | list2 = {{Navbox subgroup | ||
| groupstyle = background-color: LightYellow | | groupstyle = background-color: LightYellow | ||
| − | + | <!-- | |
| group1 = [[Plasmalemmal]] | | group1 = [[Plasmalemmal]] | ||
| list1 = ..... | | list1 = ..... | ||
| − | + | --> | |
| − | | group2 = [[Vesicular]] | + | | group2 = [[Synaptic vesicle|Vesicular]] |
| list2 = {{Navbox subgroup | | list2 = {{Navbox subgroup | ||
| groupstyle = background-color: LightYellow | | groupstyle = background-color: LightYellow | ||
| − | | group1 = [[VMAT]] | + | | group1 = [[VMAT]] inhibitors |
| list1 = [[Ibogaine]]{{•}} [[Reserpine]]{{•}} [[Tetrabenazine]] | | list1 = [[Ibogaine]]{{•}} [[Reserpine]]{{•}} [[Tetrabenazine]] | ||
| Line 41: | Line 41: | ||
}} | }} | ||
| − | | group3 = [[ | + | | group3 = [[Enzyme inhibitor|Enzyme<br>inhibitor]]s |
| list3 = {{Navbox subgroup | | list3 = {{Navbox subgroup | ||
| groupstyle = background-color: LightYellow | | groupstyle = background-color: LightYellow | ||
| Line 49: | Line 49: | ||
| groupstyle = background-color: LightYellow | | groupstyle = background-color: LightYellow | ||
| − | | group1 = [[Histidine decarboxylase|HDC]] | + | | group1 = [[Histidine decarboxylase|HDC]] inhibitors |
| list1 = [[alpha-Fluoromethylhistidine|α-FMH]]{{•}} [[Brocresine]]{{•}} [[(+)-Catechin|Catechin]]{{•}} [[Cyanidanol-3]]{{•}} [[McN-A-1293]]{{•}} [[3-methoxy-5,7,3'4'-tetrahydroxyflavan|ME]]{{•}} [[Meciadanol]]{{•}} [[Naringenin]]{{•}} [[Thiazol-4-yimethoxyamine]]{{•}} [[Tritoqualine]]{{•}} [[Zy-15,029]] | | list1 = [[alpha-Fluoromethylhistidine|α-FMH]]{{•}} [[Brocresine]]{{•}} [[(+)-Catechin|Catechin]]{{•}} [[Cyanidanol-3]]{{•}} [[McN-A-1293]]{{•}} [[3-methoxy-5,7,3'4'-tetrahydroxyflavan|ME]]{{•}} [[Meciadanol]]{{•}} [[Naringenin]]{{•}} [[Thiazol-4-yimethoxyamine]]{{•}} [[Tritoqualine]]{{•}} [[Zy-15,029]] | ||
| Line 58: | Line 58: | ||
| groupstyle = background-color: LightYellow | | groupstyle = background-color: LightYellow | ||
| − | | group1 = [[Histamine N-methyltransferase|HNMT]] | + | | group1 = [[Histamine N-methyltransferase|HNMT]] inhibitors |
| list1 = [[Amodiaquine]]{{•}} [[BW-301U]]{{•}} [[Diphenhydramine]]{{•}} [[Harmaline]]{{•}} [[Metoprine]]{{•}} [[Quinacrine]]{{•}} [[SKF-91,488]]{{•}} [[Tacrine]] | | list1 = [[Amodiaquine]]{{•}} [[BW-301U]]{{•}} [[Diphenhydramine]]{{•}} [[Harmaline]]{{•}} [[Metoprine]]{{•}} [[Quinacrine]]{{•}} [[SKF-91,488]]{{•}} [[Tacrine]] | ||
| − | | group2 = [[Diamine oxidase|DAO]] | + | | group2 = [[Diamine oxidase|DAO]] inhibitors |
| list2 = [[1,4-Diamino-2-butyne]]{{•}} [[Aminoguanidine]] | | list2 = [[1,4-Diamino-2-butyne]]{{•}} [[Aminoguanidine]] | ||
| Line 76: | Line 76: | ||
| group2 = [[Cofactor (biochemistry)|Cofactor]]s | | group2 = [[Cofactor (biochemistry)|Cofactor]]s | ||
| − | | list2 = [[Vitamin B6]] ([[ | + | | list2 = [[Vitamin B6]] ([[pyridoxine]], [[pyridoxamine]], [[pyridoxal]] → [[Pyridoxal phosphate]]) |
}} | }} | ||
}}<noinclude>[[Category:Drug templates]]</noinclude> | }}<noinclude>[[Category:Drug templates]]</noinclude> | ||
| − | |||
Latest revision as of 16:53, 27 September 2010
Lua error in package.lua at line 80: module 'Module:Color contrast' not found.
